Search Results | Clear Search | Previous (in doc) | Next (in doc) | Prev Doc | Next Doc

"Point in Time" Regulation Content

Venereal Disease Act

Venereal Disease Act Treatment Regulation

B.C. Reg. 64/84

 Regulation BEFORE repealed by BC Reg 18/2009, effective March 31, 2009.

B.C. Reg. 64/84
Regulation of the Minister of Health
Deposited March 8, 1984

Venereal Disease Act

Venereal Disease Act Treatment Regulation

 Interpretation

1  In this regulation:

"Act" means Venereal Disease Act;

"Canadian Guidelines" means the most current edition of the Canadian Guidelines for the Treatment of Sexually Transmitted Diseases published by Health Canada.

[am. B.C. Reg. 164/97, s. 1.]

 Adequate treatment

2  For the purposes of section 1 of the Act, adequate treatment is

(a) for venereal diseases discussed in the Canadian Guidelines, the treatment set out in the Canadian Guidelines and any additional treatment an infected person is directed to take by his or her physician or a medical health officer, and

(b) for venereal diseases not discussed in the Canadian Guidelines, the treatment an infected person is directed to take by his or her physician or a medical health officer.

[en. B.C. Reg. 164/97, s. 2.]

Schedule A

Gonorrhea

January 24, 1984
PREFERRED TREATMENTALTERNATIVE TREATMENT

urethralAmpicillin 3.5 g orAqueous procaine penicillin G 4.8 Mu
1.M. plus probenecid 1 g
OR
Tetracycline 500 mg 4 times daily x 5 days
cervical
Amoxicillin 3 g
PLUS
Probenecid 1 g

rectal
— femaleAs for urethral/cervical
— maleAqueous procaine penicillin G 4.8 Mu
1.M. plus probenecid 1 g

pharyngealAqueous procaine penicillin G 4.8 Mu
1.M. plus probenecid 1 g
Tetracycline 500 mg 4 times daily x 5 days

pelvic inflammatory disease
— outpatientAs for urethral/cervical plus ampicillin 500
mg 4 times daily x 10-14 days
Tetracycline 500 mg po 4 times daily x 10-14 days
— hospitalized patientsCrystalline penicillin G 16-20 Mu/day I.V.
until improved to be followed by ampicillin
500 mg 4 times daily to complete a 10-14
day treatment period
Cefoxitin 2 g I.V. 8 hourly until improved to
be followed by tetracycline 500 mg 4
times daily to complete a 10-14 day
treatment period

epididymitis/
orchitis
As for urethral/cervical plus ampicillin 500 mg 4 times daily x 10 daysTetracycline 500 mg 4 times daily x 10
days

disseminated gonococcal infection
— bacteremia
— arthritis/
dermatitis
Crystalline penicillin G 12-16 Mu/day I.V. until improved to be followed by ampicillin 500 mg 4 times daily to complete a 7-10 day treatment period
OR
As for urethral/cervical plus ampicillin 500 mg 4 times daily x 7-10 days
Cefoxitin 2 g I.V. 8 hourly until improved to be followed by tetracycline 500 mg 4
times daily to complete a 7-10 day treatment period

neonates
— ophthalmia

Crystalline penicillin G 50,000 u/kg/day
I.V. in 2 doses x 7 days PLUS
Saline irrigation


children<45 kg
— urethral
— cervical
— rectal

Amoxicillin 50 kg plus probenecid 25 mg/
kg (max 1 g)
OR
Aqueous procaine penicillin G 100,000 u/
kg I.M. stat plus probenecid (as above)

Spectinomycin 40 mg/kg I.M.

penicilinase-
producing

Neisseria gonorrhoea
— urethral
— cervical
— rectal



Spectinomycin 2 g I.M.



Cefoxitin 2 g I.M. plus probenecid 1 g

— pharyngealCotrimoxazole* 9 tablets 4 times daily x 5 days
* cotrimoxazole=sulfamethoxazole/trimethoprim

All recent sexual contacts must be located, examined, cultured and offered therapy. All patients should return 3 to 7 days after completion of therapy for re-evaluation to ensure efficacy of antimicrobial therapy and to have follow-up cultures obtained from previously infected sites.

All cases must be reported to the local STD control authorities.

If incubating syphilis is a concern aqueous procaine penicillin G should be used. Ampicillin, amoxicillin and tetracycline may not be effective in aborting syphilis. Long acting tetracycline analogs, particularly doxycycline, may be used in place of tetracycline.

PREGNANCY

The penicillins and probenecid are safe during pregnancy. Tetracycline and cotrimoxazole should be avoided. In penicillin allergic patients, spectinomycin may be used although safety for use during human pregnancy has not yet been established. Erythromycin may be used in the same dosage as tetracycline but it is less effective and tests of cure are extremely important when this drug is used.

ORAL PENICILLIN AND LONG ACTING FORMS OF PENICILLIN (BENZATHINE PENICILLIN G) HAVE NO PLACE IN THE TREATMENT OF GONORRHEA.

Syphilis

PREFERRED TREATMENTALTERNATIVE TREATMENT

primary
secondary
latent of less
than 1 year's
duration.
Benzathine penicillin G 2.4 Mu I.M. at a single sessionTetracycline 500 mg 4 times daily x 15 days
OR
Aqueous procaine penicillin G 600,000 u
I.M. daily x 8 days

latent of more
than 1 year's
duration
cardiovascular
Benzathine penicillin G 2.4 Mu I.M. weekly x 3 weeksTetracycline 500 mg 4 times daily x 30 days
OR
Aqueous procaine penicillin G 600,000 u
I.M. daily x 15 days

neurosyphillisCrystalline penicillin G 3-5 Mu I.V. 4
hourly for at least 10 days

congenital
syphilis
— normal CSFBenzathine penicillin G 50,000 u/kg
I.M.at a single session
— abnormal
CSF
Crystalline penicillin G 25,000 u/kg I.V. twice daily x 10 days

All sexual contacts must be located, examined and treated especially when the index appropriate case is suffering from infectious syphilis.

Pregnant women with syphilis, who have not previously been treated, should receive penicillin in doses appropriate to the stage of the disease. Retreatment during pregnancy is unnecessary unless there is clinical or serologic evidence of new infection. Syphilis serology should be periodically re-examined during pregnancy.

Erythromycin, in the same dosage as tetracycline, should only be used in patients allergic to both penicillin and tetracycline or in penicillin-allergic pregnant women. The efficacy of this regimen has not been well established.

Examination of the cerebrospinal fluid is mandatory to establishing the diagnosis of neurosyphillis.

Individuals should be encouraged to return for repeat serology 3, 6 and 12 months following therapy. Follow-up is particularly important in patients treated with antibiotics other than penicillin.

Chancroid

PREFERRED TREATMENTALTERNATIVE TREATMENT

Erythromycin 500 mg 4 times daily
OR
Cotrimoxazole* 160/800 mg twice daily
for a minimum of 10 days or until ulcer
and/or lymph node is healed
*trimethoprim/sulfamethoxazole

[Provisions of the Venereal Disease Act, R.S.B.C. 1996, c. 475, relevant to the enactment of this regulation: section 1]